**Part 3**

**Treatment of Fibromyalgia** 

166 New Insights into Fibromyalgia

Wallace, D.J., Linker-Israeli, M., Hallegua, D., Silverman, S., Silver, D. & Weisman, M.H.

Wang, H., Moser, M., Schiltenwolf, M. & Buchner, M. (2008). Circulating cytokine levels

Wang, H., Buchner, M., Moser, M.T., Daniel, V. & Schiltenwolf, M. (2009). The role of IL-8 in

Wolfe, F., Smythe, H.A., Yunus, M.B., Bennett, R.M., Bombardier, C., Goldenberg, D.L.,

*Rheumatism*, Vol. 33, No. 2, (February 1990), pp. 160-172, ISSN 0004-3591. Wolfe, F. (1999). "Silicone related symptoms" are common in patients with fibromyalgia: no

Wolfe, F., Clauw, D.J., Fitzcharles, M.A., Goldenberg, D.L., Katz, R.S., Mease, P., Russell,

Wolfe, F., Clauw, D.J., Fitzcharles, M.A., Goldenberg, D.L., Häuser, W., Katz, R.S., Mease, P.,

Yang, Z., Tao, T., Raftery, M.J., Youssef, P., Di Girolamo, N. & Geczy, C.L. (2001)

*Leukocyte Biology*, Vol. 69, No. 6, (June 2001), pp. 986-994, ISSN 0741-5400. Zubieta, J.K., Heitzeg, M.M., Smith, Y.R., Bueller, J.A., Xu, K., Xu, Y., Koeppe, R.A., Stohler,

No. 6, (June 2011), pp. 1113-1122, ISSN 0315-162X.

2003), pp. 1240-1243, ISSN 0036-8075.

*Journal of Pain*, Vol. 25, No. 1, (January 2009), pp. 1-4, ISSN 0749-8047. Werle, E., Fischer, H.P., Müller, A., Fiehn, W. & Eich, W. (2001). Antibodies against

0324.

ISSN 0315-162X.

ISSN 0315-162X.

1172-1175, ISSN 0315-162X.

610, ISSN 2151-464X.

(2001). Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. *Rheumatology*, Vol. 40, No. 7, (July 2001), pp. 743-749, ISSN ISSN 1462-

compared to pain in patients with fibromyalgia -- a prospective longitudinal study over 6 months. *Journal of Rheumatology,* Vol. 35, No. 7, (July 2008), pp. 1366-1370,

patients with fibromyalgia: a prospective longitudinal study of 6 months. *Clinical* 

serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. *Journal of Rheumatology,* Vol. 28, No. 3, (March 2001), pp. 595-600, ISSN 0315-162X. Wilson, R.B., Gluck, O.S., Tesser, J.R., Rice, J.C., Meyer, A. & Bridges, AJ. (1999).

Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity. *Journal of Rheumatology*, Vol. 26, No. 2, (February 1999), pp. 402-407,

Tugwell, P., Campbell, S.M., Abeles, M., Clark, P., Fam, A.G., Farber, S.J., Fiechtner, J.J., Franklin, M., Gatter, R.A., Hamaty, D., Lessard, J., Lichtbroun, A.S., Masi, A.T., Mccain, G.A., Reynolds, W.J., Romano, T.J., Russell, J. & Sheon, R.P. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. *Arthritis and* 

evidence for a new disease. *Journal of Rheumatology,* Vol. 26, No. 5, (May 1999), pp.

A.S., Russell, I.J., Winfield, J.B. & Yunus, M.B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. *Arthritis Care & Research,* Vol.62, No 5, (May 2010), pp. 600-

Russell, A,S., Russell, I.J. & Winfield, J.B. (2011). Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. *Journal of Rheumatology,* Vol. 38,

Proinflammatory properties of the human S100 protein S100A12. *Journal of* 

C.S. & Goldman, D. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. *Science,* Vol. 299, No. 5610, (February
